These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33791707)

  • 21. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
    Hoffmann M; Kleine-Weber H; Schroeder S; Krüger N; Herrler T; Erichsen S; Schiergens TS; Herrler G; Wu NH; Nitsche A; Müller MA; Drosten C; Pöhlmann S
    Cell; 2020 Apr; 181(2):271-280.e8. PubMed ID: 32142651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of SARS-CoV-2 cell entry: insight from
    Gyebi GA; Adegunloye AP; Ibrahim IM; Ogunyemi OM; Afolabi SO; Ogunro OB
    J Biomol Struct Dyn; 2022 Mar; 40(5):2121-2145. PubMed ID: 33089728
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Salleh MZ; Deris ZZ
    Life (Basel); 2022 Feb; 12(2):. PubMed ID: 35207518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virtual Screening on Marine Natural Products for Discovering TMPRSS2 Inhibitors.
    Mahmudpour M; Nabipour I; Keshavarz M; Farrokhnia M
    Front Chem; 2021; 9():722633. PubMed ID: 34712648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of diminazene as a dual inhibitor of SARS-CoV-2 human host proteases TMPRSS2 and furin using cell-based assays.
    Xu YM; Inacio MC; Liu MX; Gunatilaka AAL
    Curr Res Chem Biol; 2022; 2():100023. PubMed ID: 35815069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell culture.
    Wettstein L; Knaff PM; Kersten C; Müller P; Weil T; Conzelmann C; Müller JA; Brückner M; Hoffmann M; Pöhlmann S; Schirmeister T; Landfester K; Münch J; Mailänder V
    Commun Biol; 2022 Jul; 5(1):681. PubMed ID: 35804152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells.
    Mahoney M; Damalanka VC; Tartell MA; Chung DH; Lourenço AL; Pwee D; Mayer Bridwell AE; Hoffmann M; Voss J; Karmakar P; Azouz NP; Klingler AM; Rothlauf PW; Thompson CE; Lee M; Klampfer L; Stallings CL; Rothenberg ME; Pöhlmann S; Whelan SPJ; O'Donoghue AJ; Craik CS; Janetka JW
    Proc Natl Acad Sci U S A; 2021 Oct; 118(43):. PubMed ID: 34635581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational screening of phytochemicals from three medicinal plants as inhibitors of transmembrane protease serine 2 implicated in SARS-CoV-2 infection.
    Oyedara OO; Agbedahunsi JM; Adeyemi FM; Juárez-Saldivar A; Fadare OA; Adetunji CO; Rivera G
    Phytomed Plus; 2021 Nov; 1(4):100135. PubMed ID: 35403085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2.
    Azouz NP; Klingler AM; Callahan V; Akhrymuk IV; Elez K; Raich L; Henry BM; Benoit JL; Benoit SW; Noé F; Kehn-Hall K; Rothenberg ME
    Pathog Immun; 2021; 6(1):55-74. PubMed ID: 33969249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Insights into Human Transmembrane Protease Serine-2 (TMPS2) Inhibitors against SARS-CoV2: Homology Modelling, Molecular Dynamics, and Docking Studies.
    Kishk SM; Kishk RM; Yassen ASA; Nafie MS; Nemr NA; ElMasry G; Al-Rejaie S; Simons C
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33137894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation.
    Hörnich BF; Großkopf AK; Schlagowski S; Tenbusch M; Kleine-Weber H; Neipel F; Stahl-Hennig C; Hahn AS
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33608407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein.
    Manjunathan R; Periyaswami V; Mitra K; Rosita AS; Pandya M; Selvaraj J; Ravi L; Devarajan N; Doble M
    BMC Bioinformatics; 2022 May; 23(1):180. PubMed ID: 35578172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A quantum chemical study on the anti-SARS-CoV-2 activity of TMPRSS2 inhibitors.
    Kondo A; Fujimoto KJ; Yanai T
    Phys Chem Chem Phys; 2023 Aug; 25(30):20597-20605. PubMed ID: 37477571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactive Centre Loop Mutagenesis of SerpinB3 to Target TMPRSS2 and Furin: Inhibition of SARS-CoV-2 Cell Entry and Replication.
    Singh S; O'Reilly S; Gewaid H; Bowie AG; Gautier V; Worrall DM
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the intestinal TMPRSS2 protease to prevent SARS-CoV-2 entry into enterocytes-prospects and challenges.
    Mahmoud IS; Jarrar YB
    Mol Biol Rep; 2021 May; 48(5):4667-4675. PubMed ID: 34023987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study.
    Baby K; Maity S; Mehta CH; Suresh A; Nayak UY; Nayak Y
    Eur J Pharmacol; 2021 Apr; 896():173922. PubMed ID: 33539819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic inhibition of SARS-CoV-2 cell entry by otamixaban and covalent protease inhibitors: pre-clinical assessment of pharmacological and molecular properties.
    Hempel T; Elez K; Krüger N; Raich L; Shrimp JH; Danov O; Jonigk D; Braun A; Shen M; Hall MD; Pöhlmann S; Hoffmann M; Noé F
    Chem Sci; 2021 Oct; 12(38):12600-12609. PubMed ID: 34703545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural analysis of experimental drugs binding to the SARS-CoV-2 target TMPRSS2.
    Huggins DJ
    J Mol Graph Model; 2020 Nov; 100():107710. PubMed ID: 32829149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spontaneous binding of potential COVID-19 drugs (Camostat and Nafamostat) to human serine protease TMPRSS2.
    Zhu H; Du W; Song M; Liu Q; Herrmann A; Huang Q
    Comput Struct Biotechnol J; 2021; 19():467-476. PubMed ID: 33505639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.